The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Palling David since 2008.
The trader's CIK number is 1401304.
At the time of the last reporting, Palling David was the Senior VP, Drug Deve of Amicus Therapeutics, Inc.. (stock ticker symbol FOLD).
Also see all insider trading activities at Amicus Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | FOLD | 0 | $0 | 20,000 | $201,347 | 4,924 | $3,141 |
| 2008 | FOLD | 0 | $0 | 19,750 | $250,868 | 20,000 | $12,740 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-06-26 | FOLD | Sale | 7,498 | 10.00 | 74,980 |
| 2009-06-29 | FOLD | Sale | 2,500 | 10.54 | 26,347 |
| 2009-03-30 | FOLD | Sale | 2 | 10.00 | 20 |
| 2009-03-25 | FOLD | Sale | 531 | 10.00 | 5,310 |
| 2009-03-23 | FOLD | Sale | 1,740 | 10.00 | 17,400 |
| 2009-03-19 | FOLD | Sale | 229 | 10.00 | 2,290 |
| 2009-02-03 | FOLD | Sale | 7,500 | 10.00 | 75,000 |
| 2009-01-08 | FOLD | Option Ex | 4,924 | .64 | 3,141 |
| 2008-10-30 | FOLD | Sale | 300 | 10.00 | 3,000 |
| 2008-10-31 | FOLD | Sale | 2,200 | 10.00 | 22,000 |
| 2008-09-29 | FOLD | Sale | 2,500 | 15.62 | 39,062 |
| 2008-09-08 | FOLD | Sale | 3,000 | 14.83 | 44,496 |
| 2008-08-28 | FOLD | Sale | 2,500 | 13.77 | 34,425 |
| 2008-07-28 | FOLD | Sale | 2,500 | 15.08 | 37,692 |
| 2008-04-24 | FOLD | Option Ex | 20,000 | .64 | 12,740 |
| 2008-04-01 | FOLD | Sale | 1,250 | 11.14 | 13,931 |
| 2008-02-28 | FOLD | Sale | 2,500 | 10.51 | 26,262 |
| 2008-02-01 | FOLD | Sale | 3,000 | 10.00 | 30,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Palling David (Senior VP, Drug Deve of Amicus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.